This increasing reliance on bioreactors for pharmaceutical applications significantly contributes to market growth. The growing prevalence of chronic diseases and the rise of biologics have fueled ...

Pharmaceutical-grade industrial bioreactors are associated with numerous challenges due to the inherent complexity of biological systems housed within these devices, sterility requirements ...

The Global Single-use Bioreactors Market is set to witness a healthy growth rate of 20% by 2029. Technological innovations ...

Bora Biologics, a subsidiary of Tanvex Biopharma born out of a spinoff from Bora Pharmaceuticals, is expanding CDMO operations at its San Diego facility. The new project will add 8,075 square feet of ...

Bora Biologics, a contract development and manufacturing organization (CDMO) specializing in biologics manufacturing, is ...

The installation of the new vial, syringe, and cartridge line is expected to take place throughout the coming year.

The expanded facility will feature two 2000L Cytiva XDR bioreactors and seed train, providing Bora Biologics’ clients with ...

To address the challenges in biologics manufacturing, pharmaceutical companies are ... all processes in a manufacturing plant. Automated bioreactors and purification systems ensure precise control ...

by Type of Bioreactor, Scale of Operation, Type of Cell Culture, Type of Biologics Synthesized, Application Area, End-users and Key Geographical Regions" report has been added to ...

Among the new players redefining the medical consulting industry is BioLogic Pharma Solutions, which is committed to establishing that biotech and pharmaceutical innovations are presented to the ...

The expanded facility will feature two 2000L Cytiva XDR bioreactors and seed train, providing Bora Biologics' clients with robust and scalable biologics manufacturing solutions. The upstream hall ...